Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Start date
08 Dec 2021
End date
11 Dec 2021

Access the Platform

In light of the high number of COVID-19 cases and concerns about the new SARS-CoV-2 variant, ESMO has made the decision to hold the ESMO Immuno-Oncology Congress 2021 as a virtual congress only, with no in-person participation in Geneva.

The safety of our faculty and delegates remains our top priority at this difficult time. We are confident that our virtual format will effectively disseminate the latest advances in immuno-oncology and give experts from all around the world the chance to identify promising new research avenues.

The ESMO Immuno-Oncology Congress 2021 will help shape the future of immuno-oncology and offer a vital networking platform to specialists working in the field.

We look forward to welcoming delegates online.



The ESMO Immuno-Oncology 2021 programme is now online!



The abstract submission system is now closed

ESMO Conference Certificate

Certificate of Attendance

You will be able to download and print your Certificate of Attendance upon completion of the online evaluation form Saturday 11 December, from 10.00am.


Social Media

Follow #ESMOImmuno21 on Facebook, Twitter, LinkedIn, Instagram and YouTube



Get in touch with the organisers of the ESMO Immuno-Oncology Congress 2021

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings